Cosmegen

Active Ingredient(s): Dactinomycin, Actinomycin D
FDA Approved: * December 10, 1964
Pharm Company: * OVATION PHARMS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Cosmegen Overview

Dactinomycin, also known as actinomycin D, is a chemotherapy medication used to treat a number of types of cancer.[1] This includes Wilms tumor, rhabdomyosarcoma, Ewing's sarcoma, trophoblastic neoplasm, testicular cancer, and certain types of ovarian cancer.[1] It is given by injection into a vein.[1] Most people develop side effects.[1] Common side effects include bone marrow suppression, vomiting, mouth ulcers, hair loss, live...

Read more Cosmegen Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Actinomycin

Recent Cosmegen Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Dactinomycin, Actinomycin D
  • Injection: 0.5mg/vial, 500mcg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Cosmegen: (2 results)

Sorted by National Drug Code
  • 55292-811 Cosmegen .5 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Recordati Rare Diseases, Inc.
  • 67386-811 Cosmegen .5 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Lundbeck LLC

Other drugs which contain Dactinomycin, Actinomycin D or a similar ingredient: (1 result)